Neurofibromatosis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials

Reliability of Functional Outcome Measures in Neurofibromatosis 1: Test- Retest
Condition:   Neurofibromatosis Type 1 Intervention:   Other: Outcome measures Sponsor:   Guy's and St Thomas' NHS Foundation Trust Suspended (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 11, 2022 Category: Research Source Type: clinical trials

Efficacy and Safety of REC-2282 in Patients With Progressive Neurofibromatosis Type 2 (NF2) Mutated Meningiomas
Condition:   Neurofibromatosis Type 2 Interventions:   Drug: REC-2282;   Drug: Placebo Sponsor:   Recursion Pharmaceuticals Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 23, 2021 Category: Research Source Type: clinical trials